Skip to content
DataLookout
Menu

NCT07790562

A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions

StatusActive, Not Recruiting
PhasePhase 1
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Enrollment closed, study ongoing
    • Study completion pushed from Nov 1, 2026 to Jan 2027
    • Site details revised
  2. Notable Eligibility criteria expanded, about 31 words
    • Primary completion date changed from estimate of Sep 15, 2026 to Sep 29, 2026
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Pharmacokinetic parameter of total iron in serum: maximum observed plasma concentration (Cmax)
Timeframe: -24 hour, -12 hour, and 0 hour, 10 min, 20 min, 30 min, 45 min, 1 hour, 1.25 hour, 1.5 hour, 1.75 hour, 2 hour, 3 hour, 4 hour, 6 hour, 8 hour, 10 hour, 12 hour, 24 hour, 48 hour, 72 hour, 96 hour, 144 hour, and 168 hour
Pharmacokinetic parameter of total iron in serum: area under the plasma concentration-time curve from time 0 to the last measurable concentration (AUC0-t)
Timeframe: -24 hour, -12 hour, and 0 hour, 10 min, 20 min, 30 min, 45 min, 1 hour, 1.25 hour, 1.5 hour, 1.75 hour, 2 hour, 3 hour, 4 hour, 6 hour, 8 hour, 10 hour, 12 hour, 24 hour, 48 hour, 72 hour, 96 hour, 144 hour, and 168 hour
Pharmacokinetic parameter of transferrin bound iron in serum: Cmax
Timeframe: -24 hour, -12 hour, and 0 hour, 10 min, 20 min, 30 min, 45 min, 1 hour, 1.25 hour, 1.5 hour, 1.75 hour, 2 hour, 3 hour, 4 hour, 6 hour, 8 hour, 10 hour, 12 hour, 24 hour, 48 hour, 72 hour, 96 hour, 144 hour, and 168 hour
Pharmacokinetic parameter of transferrin bound iron in serum: AUC0-t
Timeframe: -24 hour, -12 hour, and 0 hour, 10 min, 20 min, 30 min, 45 min, 1 hour, 1.25 hour, 1.5 hour, 1.75 hour, 2 hour, 3 hour, 4 hour, 6 hour, 8 hour, 10 hour, 12 hour, 24 hour, 48 hour, 72 hour, 96 hour, 144 hour, and 168 hour

Secondary (1)

Adverse Events (AEs) and Serious Adverse Events (SAE)

Arms and interventions

Test product-Ferric Derisomaltose Injection provided by Sichuan Huiyu Pharmaceutical Co., Ltd.Experimental
Reference product-held by Pharmacosmos A/SActive comparator

Drugs: Ferric Derisomaltose Injection, Ferric Derisomaltose Injection [MonoFer®]

Sites

1 site in 1 country

  • Hopeshine-Minsheng Hospital of XinzhengZhengzhou, China